Xiaojuan Lin

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 20, 2026
EZH2 in Ovarian Cancer: Mechanistic Dependencies, Therapeutic Platforms and Translational Combinations.

|Jul 10, 2026
Forty-month durable partial response with well-tolerated olaparib maintenance in a 92-year-old patient with BRCA2-mutated uterine serous carcinoma: a case report.

|Jun 22, 2026
KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2-Dependent MDSC Recruitment.

Pageof 1

Frequent Collaborators

1 joint publications

Ce Bian

1 joint publications

Qingli Li

1 joint publications

An Tong

1 joint publications

Lu Yang